GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,950.00
+80.00 (1.64%)
At close: Jul 31, 2026

GeneBioTech Co. ,Ltd Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,5893,7892,8652,5911,523-484.4
Depreciation & Amortization
1,3841,3871,3681,3381,2861,244
Loss (Gain) From Sale of Assets
-11.220.15-122.26-20.6905.88
Asset Writedown & Restructuring Costs
---589.54--
Provision & Write-off of Bad Debts
-34.5-58.53-96.12-27.8336.8331.96
Other Operating Activities
645.75490.2797.551,066284.17155.03
Change in Accounts Receivable
-1,080953.98-1,6622,464-3,955-3,602
Change in Inventory
2,4692,966-2,239650.04-1,806-3,390
Change in Accounts Payable
1,486308.34-193.85-336.71-813.243,088
Change in Unearned Revenue
------1.96
Change in Income Taxes
----15.88118.62136.36
Change in Other Net Operating Assets
-2,140-2,222-1,182-929.93-353.49103.98
Operating Cash Flow
6,3087,614-463.877,369-3,679-2,713
Operating Cash Flow Growth
11359.98%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3,264-3,758-1,100-530.02-1,155-3,102
Sale of Property, Plant & Equipment
75.911224.6223.14-6.36
Sale (Purchase) of Intangibles
-1.74-1.74-82.71-236.9-18.91-12.28
Investment in Securities
-3,773-3,733124.03-4,6081,6858,397
Other Investing Activities
20.862.916.96-31.71-5.9211.41
Investing Cash Flow
-6,826-7,312-1,030-5,326649.965,745

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-15,64516,67312,39817,01514,232
Long-Term Debt Issued
-4,2401,8302,2001,3751,000
Total Debt Issued
18,74519,88518,50314,59818,39015,232
Short-Term Debt Repaid
--18,394-13,841-14,013-15,237-10,623
Long-Term Debt Repaid
--2,484-1,686-1,298-117.76-2,984
Total Debt Repaid
-18,020-20,878-15,527-15,311-15,355-13,608
Net Debt Issued (Repaid)
725.13-992.942,976-712.613,0351,625
Dividends Paid
------258.32
Other Financing Activities
-0-0--5,820
Financing Cash Flow
725.13-992.942,976-712.613,035-4,453

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
26.85-0.9546.92-9.59-657.42
Miscellaneous Cash Flow Adjustments
-0---0--
Net Cash Flow
234.82-692.081,5291,321-0.08-1,364

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,0443,856-1,5646,838-4,834-5,816
Free Cash Flow Growth
------
Free Cash Flow Margin
3.40%4.25%-1.89%8.60%-5.84%-9.26%
Free Cash Flow Per Share
353.41447.87-181.81794.19-561.41-675.39
Levered Free Cash Flow
3,0822,937-3,0645,514-5,633-5,825
Unlevered Free Cash Flow
3,4083,289-2,6625,877-5,460-5,730

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
479.7557.89621.87177.07181.3936.97
Cash Income Tax Paid
563.5486.34418.01216.78-141.85386.84
Change in Working Capital
735.242,007-5,2771,832-6,810-3,666